Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference

Published:2004-06-21 Issue:36 Volume:23 Page:6031-6039
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Sumimoto Hidetoshi,Miyagishi Makoto,Miyoshi Hiroyuki,Yamagata Shizuko,Shimizu Ayako,Taira Kazunari,Kawakami Yutaka

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1207812.pdf

Reference40 articles.

1. Abbas-Terki T, Blanco-Bose W, Deglon N, Pralong W and Aebischer P . (2002). Hum. Gene Ther., 13, 2197–2201.

2. Aguirre Ghiso JA, Kovalski K and Ossowski L . (1999). J. Cell Biol., 147, 89–104.

3. Barton GM and Medzhitov R . (2002). Proc. Natl. Acad. Sci. USA, 99, 14943–14945.

4. Bernstein E, Caudy AA, Hammond SM and Hannon GJ . (2001). Nature, 409, 363–366.

5. Brummelkamp TR, Bernards R and Agami R . (2002a). Science, 296, 550–553.

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor eradication by triplet therapy with BRAF inhibitor, TLR 7 agonist, and PD‐1 antibody for BRAF‐mutated melanoma;Cancer Science;2024-06-18

2. Identification of a Seven-Differentially Expressed Gene-Based Recurrence-Free Survival Model for Melanoma Patients;Disease Markers;2022-07-14

3. Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response;BMC Cancer;2021-11-13

4. Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction;PLOS ONE;2021-04-01

5. Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction;2020-05-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3